Clinical trials
Completed Phase 2 Thyroid Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Allergan | 1 |
| Eli Lilly and Company | 1 |
| Grupo Espanol de Tumores Neuroendocrinos | 1 |
| Karo Bio AB | 1 |
| MBX Biosciences | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Stanford University | 1 |
| University of Sao Paulo General Hospital | 1 |
| University of Wisconsin, Madison | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Diseases | 11 |
| Hypothyroidism | 2 |
| Thyroid Neoplasms | 2 |
| Adenolymphoma | 1 |
| Dyslipidemias | 1 |
| Head and Neck Neoplasms | 1 |
| Hypercholesterolemia | 1 |
| Hypoparathyroidism | 1 |
| Laryngeal Diseases | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.